Description
CORRECTION TO MOD P00003 - A NEW BPA WILL NOT BE ESTABLISHED UNDER THE NEW FSS CONTRACT
Base award description: BPA FOR SUBLOCADE
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-02-28+$0= $0
- Mod P000012019-12-12+$0= $0
- Mod P000022020-01-29+$0= $0
- Mod P000032020-06-29+$0= $0
- Mod P000042020-06-29+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-02-28 | +$0 | $0 | BPA FOR SUBLOCADE |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-12-12 | +$0 | $0 | 2020 PUBLIC LAW PRICING UPDATES. |
| Mod P00002· EXERCISE AN OPTION | 2020-01-29 | +$0 | $0 | EXERCISE THE FIRST OPTION YEAR FOR BPA 36E79719A0011 FOR SUBLOCADE |
| Mod P00003· LEGAL CONTRACT CANCELLATION | 2020-06-29 | +$0 | $0 | BPA CANCELLATION DUE TO PARENT FSS CANCELLATION |
| Mod P00004· OTHER ADMINISTRATIVE ACTION | 2020-06-29 | +$0 | $0 | CORRECTION TO MOD P00003 - A NEW BPA WILL NOT BE ESTABLISHED UNDER THE NEW FSS CONTRACT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI VLCNBHCXCCJ9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79726D0115 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36F79720D0156 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2020 |
| 36C24920N0359 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $10,849 | FY2020 |
| V797P2125D | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2012 |
| VA512P11706 | 512-BALTIMORE · 6515 · MED & SURGICAL INSTRUMENTS,EQ & SUP | $24,481 | FY2011 |
| VA520A10087 | 520-BILOXI · 6505 · DRUGS AND BIOLOGICALS | $4,619 | FY2011 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0025 | CHIESI USA INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79719A0011_3600 · retrieved 2026-09-26.